Theranostics in targeting fibroblast activation protein bearing cells: Progress and challenges
Life Sciences · 2023-09 · 329 · 121970
DOI: 10.1016/j.lfs.2023.121970 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Life Sciences, 2023-09. Verfasst von Sahar Rezaei und 4 weiteren Autor:innen. Beteiligte Einrichtung: Research Center for Pharmaceutical Nanotechnology, Tabriz University of Medical Sciences, Tabriz, Iran; Department of Nuclear Medicine, Faculty of Me…. Hauptthemen laut MEDLINE: Neoplasms, Cancer-Associated Fibroblasts. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 137 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, Research Center for Pharmaceutical Nanotechnology, Tabriz University of Medical Sciences.
Abstract (Originalsprache)
Cancer cells are surrounded by a complex and highly dynamic tumor microenvironment (TME). Cancer-associated fibroblasts (CAFs), a critical component of TME, contribute to cancer cell proliferation as well as metastatic spread. CAFs express a variety of biomarkers, which can be targeted for detection and therapy. Most importantly, CAFs express high levels of fibroblast activation protein (FAP) which contributes to progression of cancer, invasion, metastasis, migration, immunosuppression, and drug resistance. As a consequence, FAP is an attractive theranostic target. In this review, we discuss the latest advancement in targeting FAP in oncology using theranostic biomarkers and imaging modalities such as single-photon emission computed tomography (SPECT), positron emission tomography (PET), computed tomography (CT), fluorescence imaging, and magnetic resonance imaging (MRI).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Research Center for Pharmaceutical Nanotechnology, Tabriz University of Medical Sciences, Tabriz, Iran; Department of Nuclear Medicine, Faculty of Medicine, Imam Reza General Hospital, Tabriz University of Medical Scien…
- Department of Nuclear Medicine, Faculty of Medicine, Imam Reza General Hospital, Tabriz University of Medical Sciences, Tabriz, Iran.
- Departments of Radiology, Massachusetts General Hospital, Boston, United States.
Förderung
- NCI NIH HHS
- Research Center for Pharmaceutical Nanotechnology
- Tabriz University of Medical Sciences
Zitieren
APA
Rezaei, S., Gharapapagh, E., Dabiri, S., Heidari, P., & Aghanejad, A. (2023). Theranostics in targeting fibroblast activation protein bearing cells: Progress and challenges. Life Sciences, 329, 121970. https://doi.org/10.1016/j.lfs.2023.121970
Vancouver
Rezaei S, Gharapapagh E, Dabiri S, Heidari P, Aghanejad A. Theranostics in targeting fibroblast activation protein bearing cells: Progress and challenges. Life Sciences. 2023;329:121970. doi:10.1016/j.lfs.2023.121970
BibTeX
@article{Rezaei2023,
author = {Rezaei, Sahar and Gharapapagh, Esmaeil and Dabiri, Shahram and Heidari, Pedram and Aghanejad, Ayuob},
title = {Theranostics in targeting fibroblast activation protein bearing cells: Progress and challenges},
journal = {Life Sciences},
year = {2023},
volume = {329},
pages = {121970},
doi = {10.1016/j.lfs.2023.121970}
}
EUVIMED